PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Phone561-526-4444
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$273.80 million
Profitability
Miscellaneous
Employees187
OptionableOptionable
Petmed Express (NASDAQ:PETS) Frequently Asked Questions
What is Petmed Express' stock symbol?
Petmed Express trades on the NASDAQ under the ticker symbol "PETS."
How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?
Petmed Express announced a quarterly dividend on Tuesday, January 22nd. Shareholders of record on Monday, February 4th will be paid a dividend of $0.27 per share on Friday, February 15th. This represents a $1.08 dividend on an annualized basis and a yield of 5.16%. View Petmed Express' Dividend History.
How were Petmed Express' earnings last quarter?
Petmed Express Inc (NASDAQ:PETS) posted its quarterly earnings results on Tuesday, January, 22nd. The company reported $0.38 earnings per share for the quarter, missing analysts' consensus estimates of $0.48 by $0.10. The business earned $60.10 million during the quarter, compared to analysts' expectations of $64.22 million. Petmed Express had a net margin of 14.88% and a return on equity of 35.53%. The firm's quarterly revenue was up .0% on a year-over-year basis. During the same quarter last year, the firm posted $0.44 EPS. View Petmed Express' Earnings History.
What price target have analysts set for PETS?
2 equities research analysts have issued 1-year price objectives for Petmed Express' shares. Their forecasts range from $32.00 to $32.00. On average, they anticipate Petmed Express' share price to reach $32.00 in the next twelve months. This suggests a possible upside of 52.9% from the stock's current price. View Analyst Price Targets for Petmed Express.
What is the consensus analysts' recommendation for Petmed Express?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.
Has Petmed Express been receiving favorable news coverage?
Press coverage about PETS stock has trended very positive on Wednesday, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Petmed Express earned a news impact score of 3.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are some of Petmed Express' key competitors?
Who are Petmed Express' key executives?
Petmed Express' management team includes the folowing people:
- Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
- Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
- Ms. Alison Berges, Corp. Sec. & Gen. Counsel
Who are Petmed Express' major shareholders?
Petmed Express' stock is owned by many different of institutional and retail investors. Top institutional shareholders include North Star Investment Management Corp. (0.55%), Profit Investment Management LLC (0.50%), Menlo Advisors LLC (0.45%), Personal Capital Advisors Corp (0.45%), First Hawaiian Bank (0.04%) and Sterling Investment Advisors Ltd. (0.01%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.
Which major investors are selling Petmed Express stock?
PETS stock was sold by a variety of institutional investors in the last quarter, including Menlo Advisors LLC, Kessler Investment Group LLC and Sterling Investment Advisors Ltd.. Company insiders that have sold Petmed Express company stock in the last year include Frank J Formica, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for Petmed Express.
Which major investors are buying Petmed Express stock?
PETS stock was purchased by a variety of institutional investors in the last quarter, including Profit Investment Management LLC, North Star Investment Management Corp., First Hawaiian Bank and Personal Capital Advisors Corp. View Insider Buying and Selling for Petmed Express.
How do I buy shares of Petmed Express?
Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Petmed Express' stock price today?
One share of PETS stock can currently be purchased for approximately $20.93.
How big of a company is Petmed Express?
Petmed Express has a market capitalization of $432.71 million and generates $273.80 million in revenue each year. Petmed Express employs 187 workers across the globe.
What is Petmed Express' official website?
How can I contact Petmed Express?
Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.
MarketBeat Community Rating for Petmed Express (NASDAQ PETS)
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
